Cite
TP53 Mutational Signature of Aristolochic in Carcinomas of the Upper Urinary Tract
MLA
Slade, Neda, et al. TP53 Mutational Signature of Aristolochic in Carcinomas of the Upper Urinary Tract. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.57a035e5b1ae..620900b36deb695076ee12a25fc84a2a&authtype=sso&custid=ns315887.
APA
Slade, N., Moriya, M., Brdar, B., Jelaković, B., Medverec, Z., Tomić, K., Karanović, S., Fernandes, A., Wu, L., & Grollman, P. A. (2012). TP53 Mutational Signature of Aristolochic in Carcinomas of the Upper Urinary Tract.
Chicago
Slade, Neda, Masaaki Moriya, Branko Brdar, Bojan Jelaković, Zvonimir Medverec, Karla Tomić, Sandra Karanović, Andrea Fernandes, Li Wu, and P. Arthur Grollman. 2012. “TP53 Mutational Signature of Aristolochic in Carcinomas of the Upper Urinary Tract,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.57a035e5b1ae..620900b36deb695076ee12a25fc84a2a&authtype=sso&custid=ns315887.